LONDON--(EON: Enhanced Online News)--Technavio’s latest report on the global
cryoablation devices marketprovides an analysis of the
most important trends expected to impact the market outlook from
2017-2021. Technavio
defines an emerging trend as a factor that has the potential to
significantly impact the market and contribute to its growth or decline.

“Mergers and acquisitions are commonly adopted as an effective
growth strategy by the top companies in the cryoablation devices market.
Through mergers and acquisitions, the companies successfully expand
their geographical presence, technological capabilities, and consumers”

The research study by Technavio on the global
cryoablation devices market for 2017-2021 provides a detailed
industry analysis based on the product (cryoablation systems and
catheters and accessories), end-users (hospitals and specialty clinics
and ambulatory surgical centers), and geography (the Americas, EMEA, and
APAC).

Cryoablation is a process that uses extreme cold to destroy
diseased tissue. It employs a cryogenic material, such as liquid
nitrogen, to freeze cancer cells. It is considered as an effective
treatment modality for prostate cancer and is also used for the
treatment of other cancers of the bone, cervix, lungs, and liver.
Technavio analysts forecast the global cryoablation devices market
to grow at a CAGR of more than 6% over the forecast period.

Technavio’s sample reports are free of charge and contain multiple
sections of the report including the market size and forecast, drivers,
challenges, trends, and more.

Market growth through mergers and acquisitions

“Mergers and acquisitions are commonly adopted as an effective
growth strategy by the top companies in the cryoablation devices market.
Through mergers and acquisitions, the companies successfully expand
their geographical presence, technological capabilities, and consumers,”
says Srinivas Sashidhar, a lead analyst at Technavio for orthopedics
and medical devices research.

CooperSurgical is a good example of how M&As can help companies grow. It
has acquired nearly 40 subsidiary companies to expand its business and
diversify its product line. Besides M&A, companies also form
partnerships with hospitals and universities, which act as clinical
research organizations (CROs). These hospitals and universities help the
companies to conduct clinical trials and generate data, which are
forwarded to the regulatory authorities for receiving product approvals.

Paradigm shift toward minimally invasive procedures

Cryoablation is considered as one of the most effective of minimally
invasive procedures, which uses frigid temperatures to kill cancer cells
while preserving the surrounding tissues. Doctors all over the world
have been using cryoablation to treat different types of cancer. It is
especially effective at destroying kidney tumors while protecting the
healthy tissues. Because the procedure is minimally invasive, patients
require a short hospital stay and experience a quick recovery.

Over the last two decades, atrial fibrillation (AF) has become an
important public health concern. Cryoballoon treatment has evolved as an
effective minimally invasive procedure for the treatment of AF. Hence,
with the advantages provided by minimally invasive procedures, the
demand for them is expected to increase in the coming years.

“Many companies are expanding their businesses in developing
countries, as these economies have immense growth potential. The
implementation of government initiatives to build healthcare
infrastructure has increased the healthcare budgets. Advances in
technology will propel the market growth in these countries,” says
Srinivas.

For example, the government of China had spent around USD 371 billion on
healthcare reforms and USD 100 billion in providing insurance to the
citizens, improving the infrastructure of public hospitals and community
healthcare facilities. The growing awareness of diagnostic procedures
and treatment options for certain cancers has created tremendous
opportunities for the growth of global vendors in the market.

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at media@technavio.com.